ARCHIVES

Davis Denies “Cherry-Picking” Data To Support Her Claims.

This article is from The Cancer Letter archive.

Vol. 34 No. 30 | August 1, 2008

Download PDF Visit The Full Archive

Related Articles

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

St. Jude Children’s Research Hospital Wins NCI Designation As Comprehensive.

May 16, 2008

The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power

October 31, 2014

NCI’s Breast Cancer Screening Guidelines Released In Draft

September 24, 1993

Dana-Farber And Merck To Collaborate On Therapeutics.

February 15, 2008

Reports On AACR Scientific Sessions

May 21, 1976